Profile
AXDX ABT BSX-PA SYK BSX MDT
Company Name Accelerate Diagnostics, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Boston Scientific Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $28.05M $204.28B $175.45B $148.86B $147.84B $112.64B
Employees 0.13K 114.00K 45.00K 52.00K 48.00K 95.00K
CEO Mr. Jack Phillips Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Michael F. Mahoney Mr. Geoffrey Straub Martha
Ratings
AXDX ABT BSX-PA SYK BSX MDT
Quant Rating Score 2 3 3 3 3
Quant Rating Sell Neutral Neutral Neutral Neutral
Trading
AXDX ABT BSX-PA SYK BSX MDT
Last Close $1.12 $117.78 $122.18 $390.49 $100.31 $87.84
High 52 $2.02 $120.98 $122.18 $395.85 $100.91 $92.27
Low 52 $0.74 $100.07 $122.18 $307.75 $59.92 $76.84
Price vs. 52 Week High -44.55 % -2.65 % 0 % -1.35 % -0.59 % -4.8 %
Price vs. 52 Week Low 51.35 % 17.7 % 0 % 26.89 % 67.41 % 14.32 %
Total Return
AXDX ABT BSX-PA SYK BSX MDT
1 Month Return 1.82 % 3.04 % 0 % 6.55 % 11.63 % 7.91 %
3 Month Return -37.43 % 0.66 % 0 % 7.5 % 14.71 % -4.8 %
6 Month Return -13.18 % 13.34 % 0 % 14.27 % 27.64 % 10.63 %
9 Month Return 17.89 % 9.47 % 0 % 16.6 % 45.4 % 8.06 %
YTD Return -6.67 % 4.13 % 0 % 8.45 % 12.3 % 9.96 %
1 Year Return -16.42 % 3.32 % 0 % 25.08 % 65.47 % 1.74 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AXDX ABT BSX-PA SYK BSX MDT
Dividend Yield Percentage (TTM) - 1.9 % - 0.83 % - 3.18 %
Dividend Paid and Capex Coverage Ration (TTM) -244.37 % 1.45 % 2.95 % 2.09 % 2.95 % 1.35 %
Dividend Per Share (TTM) - 2.24 % - 3.24 % - 2.79 %
Payout Ratio (TTM) - 65.3 % 1.29 % 33.4 % 1.29 % 84.54 %
Growth
AXDX ABT BSX-PA SYK BSX MDT
Asset Growth -51.76 % -1.64 % 8.21 % 8.21 % 8.21 % -1.06 %
Gross Profit Growth -22.8 % -9.7 % 14.01 % 13.12 % 14.01 % 3.12 %
Revenue Growth -5.43 % -8.12 % 12.29 % 11.11 % 12.29 % 3.64 %
Revenue 3 Year -51.51 % 18.5 % 40.06 % 41.29 % 40.06 % 8.85 %
Revenue 5 Year -7.11 % 32.8 % 37.78 % 48.53 % 37.78 % 7.41 %
Revenue 10 Year 7426.02 % 63.89 % 84.02 % 126.63 % 84.02 % 43.65 %
EBIT Growth 13.98 % -22.53 % 42.09 % 36.85 % 42.09 % -6.22 %
Net Income Growth 1.4 % -17.45 % 128.22 % 34.22 % 128.22 % -2.18 %
Net Income 3 Yeari Growth Per Share 64.63 % 30.18 % 1209.43 % 95.8 % 1209.43 % 3.26 %
Net Income 5 Yeari Growth Per Share 69.53 % 144.68 % -9.39 % -12.21 % -9.39 % -19.5 %
Net Income 10 Yeari Growth Per Share -21.51 % 98.34 % 1315.23 % 213.78 % 1315.23 % -9.48 %
Operating Income Growth 13.98 % -22.53 % 42.09 % 36.85 % 42.09 % -6.22 %
Operating Cash Flow Growth (CFG) 17.51 % -24.21 % 64.02 % 41.43 % 64.02 % 12.39 %
Operating 3 Year CFG 64.19 % -6.04 % 61.83 % 12.02 % 61.83 % 10.18 %
Operating 5 Year CFG 74.09 % 16.69 % 667.41 % 40.12 % 667.41 % -1.78 %
Operating 10 Year CFG -24.25 % 95.01 % 113.53 % 96.25 % 113.53 % 3.3 %
EPS Growth 35.09 % -16.24 % 140 % 33.87 % 140 % -2.12 %
EPS Diluted Growth 35.09 % -16.37 % 137.78 % 33.71 % 137.78 % -2.13 %
Book Value Per Share 41.18 % 6.36 % 9.41 % 11.49 % 9.41 % -2.26 %
Share Holder 3 Year Equity Growth Per Share 85.79 % 20.39 % 22.66 % 40.57 % 22.66 % -1.1 %
Share Holder 5 Year Equity Growth Per Share -115.14 % 28.04 % 110.05 % 56.21 % 110.05 % 1.66 %
Share Holder 10 Year Equity Growth Per Share -114.44 % 36.91 % 172.19 % 104.97 % 172.19 % 94.93 %
Dividend Per Share Growth - 8.64 % -49.88 % 7.97 % -49.88 % 1.54 %
Dividend 3 Year Growth Per Share - 42.02 % -2.5 % 30.56 % -2.5 % 19.02 %
Dividend 5 Year Growth Per Share - 82.38 % - 59.67 % - 38.05 %
Dividend 10 Year Growth Per Share - 259.93 % - 183.29 % - 147.94 %
Debt Growth -49.42 % -10.4 % 2.26 % -0.41 % 2.26 % 6.91 %
Free Cash Flow Growth 16.34 % -35.17 % 86.32 % 54.03 % 86.32 % 13.54 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 26 Apr 2024
Profitability
AXDX ABT BSX-PA SYK BSX MDT
Gross Profit Margin TTM 24.08 % 54.7 % 67.3 % 62.47 % 67.3 % 62.65 %
Return on Assets TTM -165.42 % 7.76 % 4.7 % 8.19 % 4.7 % 4.76 %
Return on Equity TTM 165.71 % 14.74 % 8.91 % 18.49 % 8.91 % 8.64 %
Return on Capital Employed TTM -254.54 % 11.6 % 8.57 % 12.38 % 8.57 % 7.56 %
Net Income Per EBT TTM 101.07 % 85.08 % 81.24 % 85.68 % 81.24 % 83.18 %
EBT Per Ebit TTM 147.82 % 98.29 % 79.87 % 93.61 % 79.87 % 87.63 %
EBIT Per Revenue TTM -301.13 % 16.73 % 17.33 % 20.37 % 17.33 % 17.83 %
Cash Flow To Debt Ratio TTM -45.58 % 58.27 % 26.08 % 24.79 % 26.08 % 25.4 %
Receivables Turnover TTM 5.86 4.48 6.36 5.88 6.36 5.27
Payables Turnover TTM 1.91 4.63 5.74 6.17 5.74 5.19
Inventory Turnover TTM 3.03 2.74 1.89 1.56 1.89 2.25
Fixed Asset Turnover TTM 288.68 % 388.07 % 454.83 % 557.01 % 454.83 % 512.52 %
Asset Turnover TTM 36.77 % 55.43 % 41.78 % 50.13 % 41.78 % 36.65 %
Operating Cash Flow Per Share TTM -1.08 5.03 1.99 10.07 1.99 5.61
Free Cash Flow Per Share TTM -1.08 3.74 1.33 8.41 1.33 4.29
Cash Per Share TTM 83.93 % 449.02 % 169.89 % 1229.07 % 169.89 % 622.97 %
Operating Cash Flow Sales Ratio TTM -226.23 % 21.18 % 18.45 % 17.47 % 18.45 % 21.81 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.41 % 74.31 % 66.93 % 83.49 % 66.93 % 76.43 %
Cash Flow Coverage Ratios TTM -45.58 % 58.27 % 26.08 % 24.79 % 26.08 % 25.4 %
Price To Free Cash Flows Ratio TTM -1.04 31.5 75.88 46.45 75.24 20.48
Price To Operating Cash Flows Ratio TTM -1.04 23.41 50.75 38.76 50.32 15.66
Price Cash Flow Ratio TTM -1.04 23.41 50.75 38.76 50.32 15.66
Income Statement (TTM)
AXDX ABT BSX-PA SYK BSX MDT
Revenue $0.01B $40.11B $14.24B $20.5B $14.24B $32.36B
Gross Profit $0B $22.13B $9.9B $13.1B $9.9B $21.15B
Gross Profit Ratio 21.15% 55.18% 69.49% 63.89% 69.49% 65.34%
EBITDA $-0.05B $10.61B $3.45B $4.93B $3.45B $8.2B
Net Income $-0.06B $5.72B $1.59B $3.17B $1.59B $3.68B
EPS Diluted -4.94 3.27 1.07 8.25 1.07 2.76
Balance Sheet (MRQ)
AXDX ABT BSX-PA SYK BSX MDT
Long Term Debt $0.04B $14.55B $8.96B $11.26B $8.96B $24.77B
Total Liabilities $0.05B $34.39B $15.61B $21.32B $15.61B $39.56B
Total Equity $-0.02B $38.83B $19.53B $18.59B $19.53B $50.42B
Total Investments $0B $1.18B $0.41B $0.08B $0.41B $8.34B
Total Debt $0.04B $15.87B $9.49B $13B $9.49B $26.05B
Total Assets $0.03B $73.21B $35.14B $39.91B $35.14B $89.98B
Cash Flow Statement (TTM)
AXDX ABT BSX-PA SYK BSX MDT
Net Income $-0.06B $5.72B $1.59B $3.17B $1.59B $3.68B
Inventory $0B $-0.23B $-0.66B $-0.8B $-0.66B $-0.14B
Dividends Paid $0B $-3.56B $-0.03B $-1.14B $-0.03B $-3.67B
Operating Cash Flow $-0.04B $7.26B $2.5B $3.71B $2.5B $6.79B
Capital Expenditure $-0B $-2.2B $-0.8B $-0.58B $-0.8B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 123.22
AEMD Aethlon Medical, Inc. 0.6533
AFIB Acutus Medical, Inc. 0.0695
AHCO AdaptHealth Corp. 10.26
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 235.07
ALUR Allurion Technologies Inc. 3.28
AMIX Autonomix Medical, Inc. Common Stock 2.98
ANIK Anika Therapeutics, Inc. 16.32
AORT Artivion, Inc. 30.605
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.512
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.66
AVNS Avanos Medical, Inc. 15.79
AXGN AxoGen, Inc. 18.68
AXNX Axonics, Inc. 70.98
AZYO Aziyo Biologics, Inc. 1.49
BBLG Bone Biologics Corporation 1.0902
ETFs With Exposure to AXDX
Unlock